BNRBurning Rock Biotech Limited

NAS · US · Healthcare · Diagnostics & Research · brbiotech.com

9.780USDMkt Cap: 103.14M $P/E: —3d ago

Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, an…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap103.14M $

Enterprise Value-292.26M $

Revenue (TTM)514.43M $

Gross Profit402.91M $

Net Income (TTM)-55.35M $

Revenue/Share48.67 USD

Last Price9.780 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees667

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-16.86

PEG—

EV/EBITDA6.59

EV/Revenue-0.57

P/S0.20

P/B1.34

EPS (TTM)-0.83

EPS (Forward)-0.58

52W Range

9.11059% of range10.25

52W High10.25 USD

52W Low9.110 USD

Profitability

Gross Margin74.67%

Oper. Margin-17.46%

EBITDA Margin-8.62%

Profit Margin-10.26%

ROE-10.34%

ROA-6.75%

Growth

Revenue Growth-18.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-28.44M $

CapEx (TTM)5.25M $

FCF Margin-3.69%

FCF Yield-18.39%

Net Debt-395.14M $

Net Debt/EBITDA8.91

Balance Sheet

Debt/Equity0.08

Current Ratio3.05

Quick Ratio2.71

Book Value/Sh7.283 USD

Cash/Share42.40 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateMay 15, 2024

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.8.81M

Float3.31M

Insiders4.01%

Institutions46.95%

Short Interest

Short Ratio2.5d

Short % Float0.55%

Short % Out.0.37%

Shares Short39.24K

Short (prev mo.)35.08K

Technical

SMA 509.236 (+5.9%)

SMA 20017.63 (-44.5%)

Beta1.38

S&P 52W Chg19.18%

Avg Vol (30d)4.52K

Avg Vol (10d)8.01K

Technical Indicators

RSI (14)52.6

MACD-0.0255

MACD Signal-0.0840

MACD Hist.+0.0585

BB Upper10.46 USD

BB Middle9.305 USD

BB Lower8.150 USD

BB Width24.83%

ATR (14)0.7949 USD

Vol Ratio (20d)0.86x